Biohaven Pharmaceutical Holding (BHVN) stock forecast for 2022. Forecast tables and graphs.

Biohaven Pharmaceutical Holding (BHVN) stock forecast for 2022

The forecast has been updated: June 18, 2021 9:28


Biohaven Pharmaceutical Holding stock price online today

Analyst Target Price

101.45

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

None

Last Split Date

-

Should you buy or sell Biohaven Pharmaceutical Holding stock stock today? What is the projected target price level for 2022? How much will it cost in 2022? Biohaven Pharmaceutical Holding stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2022.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $101.45 target price for Biohaven Pharmaceutical Holding stock stock.

Today 200 Day Moving Average is the support level (81.1849 $).

50 Day Moving Average is the support level (81.2289 $).




BHVN Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 106.05 100.91 114.91 12.18 %
Feb 100.56 96.91 109.30 11.33 %
Mar 105.43 99.40 112.50 11.65 %
Apr 114.59 109.05 124.42 12.36 %
May 111.82 103.70 114.52 9.45 %
Jun 107.51 101.60 110.12 7.73 %
Jul 107.63 101.12 110.95 8.86 %
Aug 110.95 108.02 115.58 6.55 %
Sep 108.26 99.09 115.41 14.14 %
Oct 114.93 111.26 123.53 9.93 %
Nov 123.27 116.09 130.19 10.83 %
Dec 136.84 125.25 147.82 15.27 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Biohaven Pharmaceutical Holding stock.


Biohaven Pharmaceutical Holding overview

Biohaven Pharmaceutical Holding Address

215 Church Street, New Haven, CT, United States, 06510

Market Capitalization

6 134 516 224 $

EBITDA

-356 321 504

PE Ratio

None

PEG Ratio

0

Dividend Per Share

None

Dividend Yield

0

EPS

-9.14

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

37.074

Trailing PE

0

Forward PE

0

EV To Revenue

58.6827

EV To EBITDA

0

52 Week High

106.565

52 Week Low

57.66

50 Day Moving Average

81.2289

200 Day Moving Average

81.1849

Shares Outstanding

65073900

Shares Float

55023903

Shares Short Prior Month

5358166

Short Ratio

11.64

Percent Insiders

12.371

Percent Institutions

95.251

Biohaven Pharmaceutical Holding stock forecast for this year


Biohaven Pharmaceutical Holding stock forecast for Jan 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 106.05. Positive monthly dynamics of the instrument is expected with 12.182% volatility is expected.

Pessimistic forecast: 100.91

Optimistic: 114.91


Biohaven Pharmaceutical Holding stock forecast for Feb 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 100.56. Negative monthly dynamics of the instrument is expected with 11.335% volatility is expected.

Pessimistic forecast: 96.91

Optimistic: 109.30


Biohaven Pharmaceutical Holding stock forecast for Mar 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 105.43. Positive monthly dynamics of the instrument is expected with 11.649% volatility is expected.

Pessimistic forecast: 99.40

Optimistic: 112.50


Biohaven Pharmaceutical Holding stock forecast for Apr 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 114.59. Positive monthly dynamics of the instrument is expected with 12.359% volatility is expected.

Pessimistic forecast: 109.05

Optimistic: 124.42


Biohaven Pharmaceutical Holding stock forecast for May 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 111.82. Negative monthly dynamics of the instrument is expected with 9.451% volatility is expected.

Pessimistic forecast: 103.70

Optimistic: 114.52


Biohaven Pharmaceutical Holding stock forecast for Jun 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 107.51. Negative monthly dynamics of the instrument is expected with 7.733% volatility is expected.

Pessimistic forecast: 101.60

Optimistic: 110.12


Biohaven Pharmaceutical Holding stock forecast for Jul 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 107.63. Positive monthly dynamics of the instrument is expected with 8.857% volatility is expected.

Pessimistic forecast: 101.12

Optimistic: 110.95


Biohaven Pharmaceutical Holding stock forecast for Aug 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 110.95. Positive monthly dynamics of the instrument is expected with 6.547% volatility is expected.

Pessimistic forecast: 108.02

Optimistic: 115.58


Biohaven Pharmaceutical Holding stock forecast for Sep 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 108.26. Negative monthly dynamics of the instrument is expected with 14.137% volatility is expected.

Pessimistic forecast: 99.09

Optimistic: 115.41


Biohaven Pharmaceutical Holding stock forecast for Oct 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 114.93. Positive monthly dynamics of the instrument is expected with 9.927% volatility is expected.

Pessimistic forecast: 111.26

Optimistic: 123.53


Biohaven Pharmaceutical Holding stock forecast for Nov 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 123.27. Positive monthly dynamics of the instrument is expected with 10.833% volatility is expected.

Pessimistic forecast: 116.09

Optimistic: 130.19


Biohaven Pharmaceutical Holding stock forecast for Dec 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 136.84. Positive monthly dynamics of the instrument is expected with 15.273% volatility is expected.

Pessimistic forecast: 125.25

Optimistic: 147.82



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 110.33 (18.06.2021) -1.16 %
AbbVie Inc.
ABBV 113.12 (18.06.2021) -1.55 %
Aeterna Zentaris Inc.
AEZS 0.9049 (17.06.2021) -4.09 %
Allakos Inc.
ALLK 89.38 (17.06.2021) 0.13 %
Allogene Therapeutics, Inc.
ALLO 24.69 (17.06.2021) -2.33 %
Amgen Inc.
AMGN 238.68 (18.06.2021) -0.86 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 15.36 (17.06.2021) 0.00 %
Aurora Cannabis Inc.
ACB 9.04 (17.06.2021) -2.38 %
Becton Dickinson and Company
BDX 240.25 (17.06.2021) -0.01 %
Biogen Inc.
BIIB 388.44 (18.06.2021) 1.28 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 94.99 (18.06.2021) 0.76 %
BioNTech SE
BNTX 212.42 (18.06.2021) -0.83 %
bluebird bio, Inc.
BLUE 32.98 (17.06.2021) 0.61 %
Boston Scientific Corp.
BSX 43.35 (17.06.2021) 1.33 %
Bristol-Myers Squibb Company
BMY 66.47 (18.06.2021) -0.45 %
Canopy Growth Corp.
CGC 23.91 (17.06.2021) -0.87 %
Castle Biosciences, Inc.
CSTL 73.46 (18.06.2021) -3.47 %
Eli Lilly and Company
LLY 218.55 (18.06.2021) -1.65 %
Emergent BioSolutions Inc.
EBS 63.12 (17.06.2021) 1.87 %
Exelixis, Inc.
EXEL 22.41 (18.06.2021) 1.27 %
G1 Therapeutics, Inc.
GTHX 21.97 (17.06.2021) 1.10 %
Gilead Sciences, Inc.
GILD 67.22 (17.06.2021) -0.16 %
GlaxoSmithKline plc
GSK 40.57 (17.06.2021) -0.22 %
GoodRx Holdings, Inc.
GDRX 37.89 (17.06.2021) 2.02 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 83.96 (18.06.2021) 1.00 %
Inovio Pharmaceuticals, Inc.
INO 8.49 (18.06.2021) -3.74 %
Johnson & Johnson
JNJ 161.98 (18.06.2021) -1.96 %
Medtronic plc.
MDT 123.23 (18.06.2021) -1.58 %
Merck & Co., Inc.
MRK 76.61 (18.06.2021) -0.80 %
Moderna, Inc.
MRNA 202.47 (17.06.2021) 2.34 %
Novartis AG
NVS 94.15 (17.06.2021) 0.38 %
Novavax, Inc.
NVAX 179.89 (17.06.2021) 2.07 %
ObsEva SA
OBSV 2.97 (17.06.2021) -0.67 %
OrganiGram Holdings Inc.
OGI 2.91 (18.06.2021) -4.28 %
Pfizer Inc.
PFE 39.48 (17.06.2021) 0.46 %
Regeneron Pharmaceuticals, Inc.
REGN 537.92 (18.06.2021) 0.36 %
Sanofi
SNY 53.24 (17.06.2021) -0.34 %
Schrodinger, Inc.
SDGR 74.01 (18.06.2021) -2.72 %
Senseonics Holdings, Inc.
SENS 3.62 (17.06.2021) -1.09 %
Sorrento Therapeutics, Inc.
SRNE 8.67 (17.06.2021) -0.34 %
Stryker Corp.
SYK 259.55 (17.06.2021) 1.23 %
Sundial Growers Inc.
SNDL 0.923 (18.06.2021) -3.85 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 10.12 (18.06.2021) -2.69 %
Thermo Fisher Scientific Inc.
TMO 482.47 (18.06.2021) -0.74 %
Tilray, Inc.
TLRY 16.91 (18.06.2021) -3.21 %
UnitedHealth Group, Inc.
UNH 397.35 (17.06.2021) 0.03 %
Veeva Systems Inc.
VEEV 306.7 (18.06.2021) 0.44 %
Zomedica Corp.
ZOM 0.9035 (17.06.2021) 0.74 %
Zynerba Pharmaceuticals, Inc.
ZYNE 5.47 (18.06.2021) -1.97 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.